Eva Ondroušková

Low-burden <i>TP53</i> mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

Jitka Malčíková, Šárka Pavlová, Barbara Vonková et al. · Blood · 2021 · 50 citations · Full text

Hematological Malignancy, Tp53 Status, Oncology +15

Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition

Lucia Sommerová, Eva Ondroušková, Bořivoj Vojtěšek et al. · BMC Cancer · 2017 · 41 citations · Full text

AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients

Eva Ondroušková, Lucia Sommerová, Rudolf Nenutil et al. · Experimental and Molecular Pathology · 2017 · 28 citations

Breast Oncology, Oncology, Her2 Expression +10

ZEB1/miR-200c/AGR2: A New Regulatory Loop Modulating the Epithelial-Mesenchymal Transition in Lung Adenocarcinomas

Lucia Sommerová, Eva Ondroušková, Andrea Martišová et al. · Cancers · 2020 · 20 citations · Full text

Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis

Eva Ondroušková, Karel Souček, Viktor Horváth et al. · Leukemia Research · 2007 · 15 citations

Mitophagy, Signal Transduction, Signaling Pathway +11